Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Giants Safety Hill Suspended Four Games by NFL for Stimulant Use

Don't Miss Out —
Follow us on:

Oct. 9 (Bloomberg) -- New York Giants safety Will Hill was suspended four games without pay after testing positive for a banned stimulant, and will be replaced on the roster by a player who just completed a suspension for the same substance.

Hill, a 22-year-old rookie, will be eligible to return to the team Nov. 5 after his ban for violating the National Football League’s performance-enhancing drug rules, the NFL said yesterday in a statement e-mailed by the Giants.

To fill his spot on the 53-man roster, the Giants added safety Tyler Sash, who just completed a four-game suspension of his own. Sash and Hill both said they tested positive for Adderall, which is used to treat attention deficit hyperactivity disorder, or ADHD.

Hill said in a statement released by the Giants that he had a doctor’s prescription for Adderall prior to signing with the team and had discussed it in a meeting with Charles Way, the player development director. Way then reviewed the league’s banned-substance list.

“I knew at that point that this may be an issue,” Hill said. He said he had already lost an appeal of the ban.

Hill joined the team on May 14. He has played in all five games this season for the Giants (3-2), recording seven tackles on defense as well as four tackles and a forced fumble on special teams. He forced the fumble on a kickoff in yesterday’s 41-27 win against the Cleveland Browns, leading to a Giants score.

To contact the reporter on this story: Mason Levinson in New York at mlevinson@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net